ANI 파마슈티컬스, Inc.
DE ˙ DB ˙ US00182C1036
€54.50 0.00 (0.00%)
2023-08-21
주가
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionFirst Trust Advisors Lp
Latest Disclosed Ownership99,747 shares
Latest Disclosed Value $ 7,670,544
First Trust Advisors Lp reports 12.83% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 13, 2026 - First Trust Advisors Lp filed a 13F-HR form disclosing ownership of 99,747 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $7,670,544 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 88,401 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 12.83% during the quarter. The current value of the position is $5,436,212 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 99,747 11,346 12.83 7,671 9.92 0.0055
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 88,401 19,012 27.40 6,978 9.79 0.0051
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 69,389 -11,825 -14.56 6,356 19.95 0.0047
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 81,214 45,613 128.12 5,299 122.37 0.0043
2025-05-14 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 35,601 3,070 9.44 2,383 32.54 0.0021
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 32,531 -4,876 -13.03 1,798 -19.41 0.0016
2024-11-13 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 37,407 -24,372 -39.45 2,232 -43.29 0.0021
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 61,779 61,779 3,934 0.0040
2020-05-06 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -22,584 -100.00 0 -100.00
2020-02-03 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 22,584 22,584 1,393 0.0024
2019-11-04 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -15,392 -100.00 0 -100.00
2019-07-30 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 15,392 270 1.79 1,265 18.56 0.0024
2019-06-19 2019-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 15,122 179 1.20 1,067 58.54 0.0021
2019-05-09 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 15,122 179 1,067
2019-02-07 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,943 2,378 18.93 673 -5.21 0.0016
2018-10-25 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12,565 12,565 710 0.0013
2016-08-04 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -17,964 -100.00 0 -100.00
2016-05-10 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 17,964 -7,382 -29.12 605 -47.12 0.0019
2016-05-04 2015-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 25,346 -6,935 -21.48 1,144 -10.27 0.0030
2016-02-03 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 25,346 1,144
2015-11-05 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 32,281 -23,337 -41.96 1,275 -63.05 0.0037
2015-08-04 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 55,618 55,618 3,451 0.0090
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.